Investors
A MESSAGE FROM OUR CEO
“We have excellent opportunities ahead of us, and we remain focused on delivering patient, company and shareholder value.”
-
April 24, 2024 RegulatoryBulletin from the extraordinary general meeting of SynAct Pharma AB
-
April 23, 2024 RegulatoryChanges in SynAct Pharma’s Nomination Committee ahead of the 2024 Annual General Meeting
SynAct Pharma AB published its year-end report for 2023 on February 23 at 07.30 CET.
Conference call and online presentation: the same day at 15.00 CET.